Lachlan Dalli
@lachlandalli.bsky.social
National Heart Foundation Postdoctoral Fellow
Stroke Epidemiologist from Monash University
Co-Chair Rising Stars Committee, Victorian Cardiovascular Research Network
Views my own
https://www.adherencelab.com
Stroke Epidemiologist from Monash University
Co-Chair Rising Stars Committee, Victorian Cardiovascular Research Network
Views my own
https://www.adherencelab.com
Reposted by Lachlan Dalli
Huge congrats to to Dr @lachlandalli.bsky.social, Eric Kuo, Prof @moniquekilkenny.bsky.social, Dr Muideen Olaiya and Prof @dominiquecad.bsky.social - the winning team of the first Global Cardiovascular Research Funders Forum (GCRFF) Data Challenge! 👏 👏
June 25, 2025 at 3:53 AM
Huge congrats to to Dr @lachlandalli.bsky.social, Eric Kuo, Prof @moniquekilkenny.bsky.social, Dr Muideen Olaiya and Prof @dominiquecad.bsky.social - the winning team of the first Global Cardiovascular Research Funders Forum (GCRFF) Data Challenge! 👏 👏
Women are less likely than men to get key stroke prevention meds - especially at younger and older ages. It's time to close the gap.
Check out our new paper published in Stroke @ahascience.bsky.social
doi.org/10.1161/STRO...
Check out our new paper published in Stroke @ahascience.bsky.social
doi.org/10.1161/STRO...
June 23, 2025 at 10:26 PM
Women are less likely than men to get key stroke prevention meds - especially at younger and older ages. It's time to close the gap.
Check out our new paper published in Stroke @ahascience.bsky.social
doi.org/10.1161/STRO...
Check out our new paper published in Stroke @ahascience.bsky.social
doi.org/10.1161/STRO...
🆕Study published in Stroke @ahajournals.bsky.social
After adjusting for age, stroke severity and comorbidties, sex differences evident in secondary prevention medications after stroke
Differences age-specific, most apparent in younger (<45y) and older (>90y) aged women
doi.org/10.1161/STRO...
After adjusting for age, stroke severity and comorbidties, sex differences evident in secondary prevention medications after stroke
Differences age-specific, most apparent in younger (<45y) and older (>90y) aged women
doi.org/10.1161/STRO...
April 29, 2025 at 11:17 AM
🆕Study published in Stroke @ahajournals.bsky.social
After adjusting for age, stroke severity and comorbidties, sex differences evident in secondary prevention medications after stroke
Differences age-specific, most apparent in younger (<45y) and older (>90y) aged women
doi.org/10.1161/STRO...
After adjusting for age, stroke severity and comorbidties, sex differences evident in secondary prevention medications after stroke
Differences age-specific, most apparent in younger (<45y) and older (>90y) aged women
doi.org/10.1161/STRO...